The Department of Revenue on August 22, 2020 has issued the Narcotic Drugs and Psychotropic Substances (Regulation of Controlled Substances) Amendment Order, 2020 to further amend the Narcotic Drugs and Psychotropic Substances (Regulation of Controlled Substances) Order, 2013.
The amendments made in the Narcotic Drugs and Psychotropic Substances (Regulation of Controlled Substances) Order, 2013 are as follows:-
• In Schedule A (Those substances whose manufacture, distribution, sale, purchase, possession, storage and consumption is subject to controls as specified in this Order), two new entries have been inserted specifying (i) 4-Anilino-N-phenethylpiperidine (ANPP) (ii) N-Phenethyl-4-piperidone (NPP) respectively.
• In Schedule B and Schedule C (Those controlled substance whose export from India is subject to controls as specified in this Order), serial no 20 to 23 have been inserted which are as follow:
• 3, 4-MDP-2-P methyl glycidate (PMK glycidate) (all stereoisomers)
• 3, 4-MDP-2-P methyl glycidic acid (PMK glycidic acid) (all stereoisomers)
• alpha-phenylacetoacetamide (APAA) (including its optical isomers)
• methyl alpha-phenylacetoacetate (MAPA) (including its optical isomers)
[Notification no G.S.R. 536(E)]
